Cargando…
Combined PARP inhibitors and small molecular inhibitors in solid tumor treatment (Review)
With the development of precision medicine, targeted therapy has attracted extensive attention. Poly(ADP-ribose) polymerase inhibitors (PARPi) are critical clinical drugs designed to induce cell death and are major antitumor targeted agents. However, preclinical and clinical data have revealed the l...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
D.A. Spandidos
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9851129/ https://www.ncbi.nlm.nih.gov/pubmed/36601757 http://dx.doi.org/10.3892/ijo.2023.5476 |